A low dose Pimobendan was observed to prolong the period until re-hospitalization for Japanese patients with advanced heart failure, especially in the vulnerable post-discharge period.
Event:
Heart Failure 2019
Topic:
Pharmacotherapy
Session:
Chronic Heart Failure – Treatment
